Indian drugmaker, Cipla Ltd, sees GLP-1 drugs, used to treat type-2 diabetes and obesity, as a significant new therapy opportunity in the Indian market.

I just thought the hustle and bustle of keeping up with everything was exhausting me. I continuously complained to my therapist that I ...

Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international ...

Cipla is looking at the whole GLP-1 category and not just Semaglutide alone, says Cipla CEO Umang Vohra in a post-results ...

Cipla reports a 10% YoY rise in Q1FY26 net profit, driven by strong performance in consumer healthcare and generics. The ...

Pediatric dermatologists must play an active role in treating obesity in children, according to a presenter at the Society ...

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.

Prof Price added: “We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms.

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...